Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), bought 8,500 shares at $1.53 ($16K) on 2021-12-02, disclosed to the SEC on 2021-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.13 | 5,000 | $11K | 66.6% |
| 2 | $1.52 | 1,322 | $2K | 12.6% |
| 3 | $1.53 | 2,178 | $3K | 20.8% |
| Total | $1.88 avg | 8,500 | $16K | 100% |
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |